JFCCX
Price
$35.64
Change
+$0.09 (+0.25%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

JFCCX vs VTSAX

Header iconJFCCX vs VTSAX Comparison
Open Charts JFCCX vs VTSAXBanner chart's image
JHancock Fundamental All Cap Core C
Price$35.64
Change+$0.09 (+0.25%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JFCCX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFCCX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFCCX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. JFCCX (602M). VTSAX pays higher dividends than JFCCX: VTSAX (1.35) vs JFCCX (0.00). JFCCX was incepted earlier than VTSAX: JFCCX (10 years) vs VTSAX (24 years). JFCCX is a more actively managed with annual turnover of: 36.00 vs. VTSAX (2.00). JFCCX has a lower initial minimum investment than VTSAX: JFCCX (1000) vs VTSAX (3000). JFCCX annual gain was more profitable for investors over the last year : 37.90 vs. VTSAX (33.39). JFCCX return over 5 years is better than : 92.47 vs. VTSAX (87.46).
JFCCXVTSAXJFCCX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years24 years-
Gain YTD26.46724.891106%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets602M1.73T0%
Annual Yield % from dividends0.001.35-
Returns for 1 year37.9033.39113%
Returns for 3 years15.8422.8269%
Returns for 5 years92.4787.46106%
Returns for 10 years135.43194.0770%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals